AKT1 and cancer: Consistent with these studies, we observed downregulation of PI3K and AKT1 mRNA levels following RRM2 knockdown in HepG2 cells, suggesting that RRM2 regulates the PI3K/AKT pathway across various cancer types, including HCC.